Global Animal Biological Vaccine Market Growth 2025-2031
The global Animal Biological Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 559%.
LP Information, Inc. (LPI) ' newest research report, the “Animal Biological Vaccine Industry Forecast” looks at past sales and reviews total world Animal Biological Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal Biological Vaccine sales for 2025 through 2031. With Animal Biological Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Biological Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Animal Biological Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal Biological Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Biological Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Biological Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Biological Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Biological Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Animal Biological Vaccine market?
What factors are driving Animal Biological Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Animal Biological Vaccine market opportunities vary by end market size?
How does Animal Biological Vaccine break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 559%.
LP Information, Inc. (LPI) ' newest research report, the “Animal Biological Vaccine Industry Forecast” looks at past sales and reviews total world Animal Biological Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal Biological Vaccine sales for 2025 through 2031. With Animal Biological Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Biological Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Animal Biological Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal Biological Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Biological Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Biological Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Biological Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Biological Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral
- Subcutaneous
- Intramuscular
- Others
- Porcine
- Poultry
- Livestock
- Companion Animals
- Aquaculture
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Zoetis
- Merial/Sanofi
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco/Eli Lilly
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal
What is the 10-year outlook for the global Animal Biological Vaccine market?
What factors are driving Animal Biological Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Animal Biological Vaccine market opportunities vary by end market size?
How does Animal Biological Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Animal Biological Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Animal Biological Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Animal Biological Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Animal Biological Vaccine Segment by Type
2.2.1 Oral
2.2.2 Subcutaneous
2.2.3 Intramuscular
2.2.4 Others
2.3 Animal Biological Vaccine Sales by Type
2.3.1 Global Animal Biological Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Animal Biological Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Animal Biological Vaccine Sale Price by Type (2020-2025)
2.4 Animal Biological Vaccine Segment by Application
2.4.1 Porcine
2.4.2 Poultry
2.4.3 Livestock
2.4.4 Companion Animals
2.4.5 Aquaculture
2.5 Animal Biological Vaccine Sales by Application
2.5.1 Global Animal Biological Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Animal Biological Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Animal Biological Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Animal Biological Vaccine Breakdown Data by Company
3.1.1 Global Animal Biological Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Animal Biological Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Animal Biological Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Animal Biological Vaccine Revenue by Company (2020-2025)
3.2.2 Global Animal Biological Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Animal Biological Vaccine Sale Price by Company
3.4 Key Manufacturers Animal Biological Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Animal Biological Vaccine Product Location Distribution
3.4.2 Players Animal Biological Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANIMAL BIOLOGICAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Animal Biological Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Animal Biological Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Animal Biological Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Animal Biological Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Animal Biological Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Animal Biological Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Animal Biological Vaccine Sales Growth
4.4 APAC Animal Biological Vaccine Sales Growth
4.5 Europe Animal Biological Vaccine Sales Growth
4.6 Middle East & Africa Animal Biological Vaccine Sales Growth
5 AMERICAS
5.1 Americas Animal Biological Vaccine Sales by Country
5.1.1 Americas Animal Biological Vaccine Sales by Country (2020-2025)
5.1.2 Americas Animal Biological Vaccine Revenue by Country (2020-2025)
5.2 Americas Animal Biological Vaccine Sales by Type (2020-2025)
5.3 Americas Animal Biological Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Animal Biological Vaccine Sales by Region
6.1.1 APAC Animal Biological Vaccine Sales by Region (2020-2025)
6.1.2 APAC Animal Biological Vaccine Revenue by Region (2020-2025)
6.2 APAC Animal Biological Vaccine Sales by Type (2020-2025)
6.3 APAC Animal Biological Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Animal Biological Vaccine by Country
7.1.1 Europe Animal Biological Vaccine Sales by Country (2020-2025)
7.1.2 Europe Animal Biological Vaccine Revenue by Country (2020-2025)
7.2 Europe Animal Biological Vaccine Sales by Type (2020-2025)
7.3 Europe Animal Biological Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Animal Biological Vaccine by Country
8.1.1 Middle East & Africa Animal Biological Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Animal Biological Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Animal Biological Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Animal Biological Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Animal Biological Vaccine
10.3 Manufacturing Process Analysis of Animal Biological Vaccine
10.4 Industry Chain Structure of Animal Biological Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Animal Biological Vaccine Distributors
11.3 Animal Biological Vaccine Customer
12 WORLD FORECAST REVIEW FOR ANIMAL BIOLOGICAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Animal Biological Vaccine Market Size Forecast by Region
12.1.1 Global Animal Biological Vaccine Forecast by Region (2026-2031)
12.1.2 Global Animal Biological Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Animal Biological Vaccine Forecast by Type (2026-2031)
12.7 Global Animal Biological Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Animal Biological Vaccine Product Portfolios and Specifications
13.1.3 Merck Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Animal Biological Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Merial/Sanofi
13.3.1 Merial/Sanofi Company Information
13.3.2 Merial/Sanofi Animal Biological Vaccine Product Portfolios and Specifications
13.3.3 Merial/Sanofi Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merial/Sanofi Main Business Overview
13.3.5 Merial/Sanofi Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Animal Biological Vaccine Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Ceva
13.5.1 Ceva Company Information
13.5.2 Ceva Animal Biological Vaccine Product Portfolios and Specifications
13.5.3 Ceva Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ceva Main Business Overview
13.5.5 Ceva Latest Developments
13.6 CAHIC
13.6.1 CAHIC Company Information
13.6.2 CAHIC Animal Biological Vaccine Product Portfolios and Specifications
13.6.3 CAHIC Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CAHIC Main Business Overview
13.6.5 CAHIC Latest Developments
13.7 HVRI
13.7.1 HVRI Company Information
13.7.2 HVRI Animal Biological Vaccine Product Portfolios and Specifications
13.7.3 HVRI Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 HVRI Main Business Overview
13.7.5 HVRI Latest Developments
13.8 Ringpu Biology
13.8.1 Ringpu Biology Company Information
13.8.2 Ringpu Biology Animal Biological Vaccine Product Portfolios and Specifications
13.8.3 Ringpu Biology Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ringpu Biology Main Business Overview
13.8.5 Ringpu Biology Latest Developments
13.9 Yebio
13.9.1 Yebio Company Information
13.9.2 Yebio Animal Biological Vaccine Product Portfolios and Specifications
13.9.3 Yebio Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Yebio Main Business Overview
13.9.5 Yebio Latest Developments
13.10 DHN
13.10.1 DHN Company Information
13.10.2 DHN Animal Biological Vaccine Product Portfolios and Specifications
13.10.3 DHN Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 DHN Main Business Overview
13.10.5 DHN Latest Developments
13.11 WINSUN
13.11.1 WINSUN Company Information
13.11.2 WINSUN Animal Biological Vaccine Product Portfolios and Specifications
13.11.3 WINSUN Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 WINSUN Main Business Overview
13.11.5 WINSUN Latest Developments
13.12 Elanco/Eli Lilly
13.12.1 Elanco/Eli Lilly Company Information
13.12.2 Elanco/Eli Lilly Animal Biological Vaccine Product Portfolios and Specifications
13.12.3 Elanco/Eli Lilly Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Elanco/Eli Lilly Main Business Overview
13.12.5 Elanco/Eli Lilly Latest Developments
13.13 Virbac
13.13.1 Virbac Company Information
13.13.2 Virbac Animal Biological Vaccine Product Portfolios and Specifications
13.13.3 Virbac Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Virbac Main Business Overview
13.13.5 Virbac Latest Developments
13.14 Jinyu Bio-Technology
13.14.1 Jinyu Bio-Technology Company Information
13.14.2 Jinyu Bio-Technology Animal Biological Vaccine Product Portfolios and Specifications
13.14.3 Jinyu Bio-Technology Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Jinyu Bio-Technology Main Business Overview
13.14.5 Jinyu Bio-Technology Latest Developments
13.15 ChengDu Tecbond
13.15.1 ChengDu Tecbond Company Information
13.15.2 ChengDu Tecbond Animal Biological Vaccine Product Portfolios and Specifications
13.15.3 ChengDu Tecbond Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 ChengDu Tecbond Main Business Overview
13.15.5 ChengDu Tecbond Latest Developments
13.16 CAVAC
13.16.1 CAVAC Company Information
13.16.2 CAVAC Animal Biological Vaccine Product Portfolios and Specifications
13.16.3 CAVAC Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 CAVAC Main Business Overview
13.16.5 CAVAC Latest Developments
13.17 Kyoto Biken
13.17.1 Kyoto Biken Company Information
13.17.2 Kyoto Biken Animal Biological Vaccine Product Portfolios and Specifications
13.17.3 Kyoto Biken Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Kyoto Biken Main Business Overview
13.17.5 Kyoto Biken Latest Developments
13.18 FATRO
13.18.1 FATRO Company Information
13.18.2 FATRO Animal Biological Vaccine Product Portfolios and Specifications
13.18.3 FATRO Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 FATRO Main Business Overview
13.18.5 FATRO Latest Developments
13.19 Vaksindo
13.19.1 Vaksindo Company Information
13.19.2 Vaksindo Animal Biological Vaccine Product Portfolios and Specifications
13.19.3 Vaksindo Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Vaksindo Main Business Overview
13.19.5 Vaksindo Latest Developments
13.20 Bio-Labs
13.20.1 Bio-Labs Company Information
13.20.2 Bio-Labs Animal Biological Vaccine Product Portfolios and Specifications
13.20.3 Bio-Labs Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Bio-Labs Main Business Overview
13.20.5 Bio-Labs Latest Developments
13.21 Avimex Animal
13.21.1 Avimex Animal Company Information
13.21.2 Avimex Animal Animal Biological Vaccine Product Portfolios and Specifications
13.21.3 Avimex Animal Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Avimex Animal Main Business Overview
13.21.5 Avimex Animal Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Animal Biological Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Animal Biological Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Animal Biological Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Animal Biological Vaccine Segment by Type
2.2.1 Oral
2.2.2 Subcutaneous
2.2.3 Intramuscular
2.2.4 Others
2.3 Animal Biological Vaccine Sales by Type
2.3.1 Global Animal Biological Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Animal Biological Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Animal Biological Vaccine Sale Price by Type (2020-2025)
2.4 Animal Biological Vaccine Segment by Application
2.4.1 Porcine
2.4.2 Poultry
2.4.3 Livestock
2.4.4 Companion Animals
2.4.5 Aquaculture
2.5 Animal Biological Vaccine Sales by Application
2.5.1 Global Animal Biological Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Animal Biological Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Animal Biological Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Animal Biological Vaccine Breakdown Data by Company
3.1.1 Global Animal Biological Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Animal Biological Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Animal Biological Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Animal Biological Vaccine Revenue by Company (2020-2025)
3.2.2 Global Animal Biological Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Animal Biological Vaccine Sale Price by Company
3.4 Key Manufacturers Animal Biological Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Animal Biological Vaccine Product Location Distribution
3.4.2 Players Animal Biological Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANIMAL BIOLOGICAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Animal Biological Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Animal Biological Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Animal Biological Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Animal Biological Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Animal Biological Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Animal Biological Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Animal Biological Vaccine Sales Growth
4.4 APAC Animal Biological Vaccine Sales Growth
4.5 Europe Animal Biological Vaccine Sales Growth
4.6 Middle East & Africa Animal Biological Vaccine Sales Growth
5 AMERICAS
5.1 Americas Animal Biological Vaccine Sales by Country
5.1.1 Americas Animal Biological Vaccine Sales by Country (2020-2025)
5.1.2 Americas Animal Biological Vaccine Revenue by Country (2020-2025)
5.2 Americas Animal Biological Vaccine Sales by Type (2020-2025)
5.3 Americas Animal Biological Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Animal Biological Vaccine Sales by Region
6.1.1 APAC Animal Biological Vaccine Sales by Region (2020-2025)
6.1.2 APAC Animal Biological Vaccine Revenue by Region (2020-2025)
6.2 APAC Animal Biological Vaccine Sales by Type (2020-2025)
6.3 APAC Animal Biological Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Animal Biological Vaccine by Country
7.1.1 Europe Animal Biological Vaccine Sales by Country (2020-2025)
7.1.2 Europe Animal Biological Vaccine Revenue by Country (2020-2025)
7.2 Europe Animal Biological Vaccine Sales by Type (2020-2025)
7.3 Europe Animal Biological Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Animal Biological Vaccine by Country
8.1.1 Middle East & Africa Animal Biological Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Animal Biological Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Animal Biological Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Animal Biological Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Animal Biological Vaccine
10.3 Manufacturing Process Analysis of Animal Biological Vaccine
10.4 Industry Chain Structure of Animal Biological Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Animal Biological Vaccine Distributors
11.3 Animal Biological Vaccine Customer
12 WORLD FORECAST REVIEW FOR ANIMAL BIOLOGICAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Animal Biological Vaccine Market Size Forecast by Region
12.1.1 Global Animal Biological Vaccine Forecast by Region (2026-2031)
12.1.2 Global Animal Biological Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Animal Biological Vaccine Forecast by Type (2026-2031)
12.7 Global Animal Biological Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Animal Biological Vaccine Product Portfolios and Specifications
13.1.3 Merck Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Animal Biological Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Merial/Sanofi
13.3.1 Merial/Sanofi Company Information
13.3.2 Merial/Sanofi Animal Biological Vaccine Product Portfolios and Specifications
13.3.3 Merial/Sanofi Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merial/Sanofi Main Business Overview
13.3.5 Merial/Sanofi Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Animal Biological Vaccine Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Ceva
13.5.1 Ceva Company Information
13.5.2 Ceva Animal Biological Vaccine Product Portfolios and Specifications
13.5.3 Ceva Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ceva Main Business Overview
13.5.5 Ceva Latest Developments
13.6 CAHIC
13.6.1 CAHIC Company Information
13.6.2 CAHIC Animal Biological Vaccine Product Portfolios and Specifications
13.6.3 CAHIC Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CAHIC Main Business Overview
13.6.5 CAHIC Latest Developments
13.7 HVRI
13.7.1 HVRI Company Information
13.7.2 HVRI Animal Biological Vaccine Product Portfolios and Specifications
13.7.3 HVRI Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 HVRI Main Business Overview
13.7.5 HVRI Latest Developments
13.8 Ringpu Biology
13.8.1 Ringpu Biology Company Information
13.8.2 Ringpu Biology Animal Biological Vaccine Product Portfolios and Specifications
13.8.3 Ringpu Biology Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ringpu Biology Main Business Overview
13.8.5 Ringpu Biology Latest Developments
13.9 Yebio
13.9.1 Yebio Company Information
13.9.2 Yebio Animal Biological Vaccine Product Portfolios and Specifications
13.9.3 Yebio Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Yebio Main Business Overview
13.9.5 Yebio Latest Developments
13.10 DHN
13.10.1 DHN Company Information
13.10.2 DHN Animal Biological Vaccine Product Portfolios and Specifications
13.10.3 DHN Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 DHN Main Business Overview
13.10.5 DHN Latest Developments
13.11 WINSUN
13.11.1 WINSUN Company Information
13.11.2 WINSUN Animal Biological Vaccine Product Portfolios and Specifications
13.11.3 WINSUN Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 WINSUN Main Business Overview
13.11.5 WINSUN Latest Developments
13.12 Elanco/Eli Lilly
13.12.1 Elanco/Eli Lilly Company Information
13.12.2 Elanco/Eli Lilly Animal Biological Vaccine Product Portfolios and Specifications
13.12.3 Elanco/Eli Lilly Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Elanco/Eli Lilly Main Business Overview
13.12.5 Elanco/Eli Lilly Latest Developments
13.13 Virbac
13.13.1 Virbac Company Information
13.13.2 Virbac Animal Biological Vaccine Product Portfolios and Specifications
13.13.3 Virbac Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Virbac Main Business Overview
13.13.5 Virbac Latest Developments
13.14 Jinyu Bio-Technology
13.14.1 Jinyu Bio-Technology Company Information
13.14.2 Jinyu Bio-Technology Animal Biological Vaccine Product Portfolios and Specifications
13.14.3 Jinyu Bio-Technology Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Jinyu Bio-Technology Main Business Overview
13.14.5 Jinyu Bio-Technology Latest Developments
13.15 ChengDu Tecbond
13.15.1 ChengDu Tecbond Company Information
13.15.2 ChengDu Tecbond Animal Biological Vaccine Product Portfolios and Specifications
13.15.3 ChengDu Tecbond Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 ChengDu Tecbond Main Business Overview
13.15.5 ChengDu Tecbond Latest Developments
13.16 CAVAC
13.16.1 CAVAC Company Information
13.16.2 CAVAC Animal Biological Vaccine Product Portfolios and Specifications
13.16.3 CAVAC Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 CAVAC Main Business Overview
13.16.5 CAVAC Latest Developments
13.17 Kyoto Biken
13.17.1 Kyoto Biken Company Information
13.17.2 Kyoto Biken Animal Biological Vaccine Product Portfolios and Specifications
13.17.3 Kyoto Biken Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Kyoto Biken Main Business Overview
13.17.5 Kyoto Biken Latest Developments
13.18 FATRO
13.18.1 FATRO Company Information
13.18.2 FATRO Animal Biological Vaccine Product Portfolios and Specifications
13.18.3 FATRO Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 FATRO Main Business Overview
13.18.5 FATRO Latest Developments
13.19 Vaksindo
13.19.1 Vaksindo Company Information
13.19.2 Vaksindo Animal Biological Vaccine Product Portfolios and Specifications
13.19.3 Vaksindo Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Vaksindo Main Business Overview
13.19.5 Vaksindo Latest Developments
13.20 Bio-Labs
13.20.1 Bio-Labs Company Information
13.20.2 Bio-Labs Animal Biological Vaccine Product Portfolios and Specifications
13.20.3 Bio-Labs Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Bio-Labs Main Business Overview
13.20.5 Bio-Labs Latest Developments
13.21 Avimex Animal
13.21.1 Avimex Animal Company Information
13.21.2 Avimex Animal Animal Biological Vaccine Product Portfolios and Specifications
13.21.3 Avimex Animal Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Avimex Animal Main Business Overview
13.21.5 Avimex Animal Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Animal Biological Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Animal Biological Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Subcutaneous
Table 5. Major Players of Intramuscular
Table 6. Major Players of Others
Table 7. Global Animal Biological Vaccine Sales by Type (2020-2025) & (K Units)
Table 8. Global Animal Biological Vaccine Sales Market Share by Type (2020-2025)
Table 9. Global Animal Biological Vaccine Revenue by Type (2020-2025) & ($ million)
Table 10. Global Animal Biological Vaccine Revenue Market Share by Type (2020-2025)
Table 11. Global Animal Biological Vaccine Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Animal Biological Vaccine Sale by Application (2020-2025) & (K Units)
Table 13. Global Animal Biological Vaccine Sale Market Share by Application (2020-2025)
Table 14. Global Animal Biological Vaccine Revenue by Application (2020-2025) & ($ million)
Table 15. Global Animal Biological Vaccine Revenue Market Share by Application (2020-2025)
Table 16. Global Animal Biological Vaccine Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Animal Biological Vaccine Sales by Company (2020-2025) & (K Units)
Table 18. Global Animal Biological Vaccine Sales Market Share by Company (2020-2025)
Table 19. Global Animal Biological Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Animal Biological Vaccine Revenue Market Share by Company (2020-2025)
Table 21. Global Animal Biological Vaccine Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Animal Biological Vaccine Producing Area Distribution and Sales Area
Table 23. Players Animal Biological Vaccine Products Offered
Table 24. Animal Biological Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Animal Biological Vaccine Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Animal Biological Vaccine Sales Market Share Geographic Region (2020-2025)
Table 29. Global Animal Biological Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Animal Biological Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Animal Biological Vaccine Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Animal Biological Vaccine Sales Market Share by Country/Region (2020-2025)
Table 33. Global Animal Biological Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Animal Biological Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Animal Biological Vaccine Sales by Country (2020-2025) & (K Units)
Table 36. Americas Animal Biological Vaccine Sales Market Share by Country (2020-2025)
Table 37. Americas Animal Biological Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Animal Biological Vaccine Sales by Type (2020-2025) & (K Units)
Table 39. Americas Animal Biological Vaccine Sales by Application (2020-2025) & (K Units)
Table 40. APAC Animal Biological Vaccine Sales by Region (2020-2025) & (K Units)
Table 41. APAC Animal Biological Vaccine Sales Market Share by Region (2020-2025)
Table 42. APAC Animal Biological Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Animal Biological Vaccine Sales by Type (2020-2025) & (K Units)
Table 44. APAC Animal Biological Vaccine Sales by Application (2020-2025) & (K Units)
Table 45. Europe Animal Biological Vaccine Sales by Country (2020-2025) & (K Units)
Table 46. Europe Animal Biological Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Animal Biological Vaccine Sales by Type (2020-2025) & (K Units)
Table 48. Europe Animal Biological Vaccine Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Animal Biological Vaccine Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Animal Biological Vaccine Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Animal Biological Vaccine Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Animal Biological Vaccine Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Animal Biological Vaccine
Table 54. Key Market Challenges & Risks of Animal Biological Vaccine
Table 55. Key Industry Trends of Animal Biological Vaccine
Table 56. Animal Biological Vaccine Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Animal Biological Vaccine Distributors List
Table 59. Animal Biological Vaccine Customer List
Table 60. Global Animal Biological Vaccine Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Animal Biological Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Animal Biological Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Animal Biological Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Animal Biological Vaccine Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Animal Biological Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Animal Biological Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Animal Biological Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Animal Biological Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Animal Biological Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Animal Biological Vaccine Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Animal Biological Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Animal Biological Vaccine Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Animal Biological Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Merck Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 75. Merck Animal Biological Vaccine Product Portfolios and Specifications
Table 76. Merck Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Merck Main Business
Table 78. Merck Latest Developments
Table 79. Zoetis Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Zoetis Animal Biological Vaccine Product Portfolios and Specifications
Table 81. Zoetis Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Zoetis Main Business
Table 83. Zoetis Latest Developments
Table 84. Merial/Sanofi Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Merial/Sanofi Animal Biological Vaccine Product Portfolios and Specifications
Table 86. Merial/Sanofi Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Merial/Sanofi Main Business
Table 88. Merial/Sanofi Latest Developments
Table 89. Boehringer Ingelheim Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Boehringer Ingelheim Animal Biological Vaccine Product Portfolios and Specifications
Table 91. Boehringer Ingelheim Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Boehringer Ingelheim Main Business
Table 93. Boehringer Ingelheim Latest Developments
Table 94. Ceva Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Ceva Animal Biological Vaccine Product Portfolios and Specifications
Table 96. Ceva Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Ceva Main Business
Table 98. Ceva Latest Developments
Table 99. CAHIC Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CAHIC Animal Biological Vaccine Product Portfolios and Specifications
Table 101. CAHIC Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. CAHIC Main Business
Table 103. CAHIC Latest Developments
Table 104. HVRI Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. HVRI Animal Biological Vaccine Product Portfolios and Specifications
Table 106. HVRI Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. HVRI Main Business
Table 108. HVRI Latest Developments
Table 109. Ringpu Biology Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Ringpu Biology Animal Biological Vaccine Product Portfolios and Specifications
Table 111. Ringpu Biology Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Ringpu Biology Main Business
Table 113. Ringpu Biology Latest Developments
Table 114. Yebio Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Yebio Animal Biological Vaccine Product Portfolios and Specifications
Table 116. Yebio Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Yebio Main Business
Table 118. Yebio Latest Developments
Table 119. DHN Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. DHN Animal Biological Vaccine Product Portfolios and Specifications
Table 121. DHN Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. DHN Main Business
Table 123. DHN Latest Developments
Table 124. WINSUN Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. WINSUN Animal Biological Vaccine Product Portfolios and Specifications
Table 126. WINSUN Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. WINSUN Main Business
Table 128. WINSUN Latest Developments
Table 129. Elanco/Eli Lilly Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Elanco/Eli Lilly Animal Biological Vaccine Product Portfolios and Specifications
Table 131. Elanco/Eli Lilly Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Elanco/Eli Lilly Main Business
Table 133. Elanco/Eli Lilly Latest Developments
Table 134. Virbac Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Virbac Animal Biological Vaccine Product Portfolios and Specifications
Table 136. Virbac Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Virbac Main Business
Table 138. Virbac Latest Developments
Table 139. Jinyu Bio-Technology Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Jinyu Bio-Technology Animal Biological Vaccine Product Portfolios and Specifications
Table 141. Jinyu Bio-Technology Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Jinyu Bio-Technology Main Business
Table 143. Jinyu Bio-Technology Latest Developments
Table 144. ChengDu Tecbond Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 145. ChengDu Tecbond Animal Biological Vaccine Product Portfolios and Specifications
Table 146. ChengDu Tecbond Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. ChengDu Tecbond Main Business
Table 148. ChengDu Tecbond Latest Developments
Table 149. CAVAC Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 150. CAVAC Animal Biological Vaccine Product Portfolios and Specifications
Table 151. CAVAC Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. CAVAC Main Business
Table 153. CAVAC Latest Developments
Table 154. Kyoto Biken Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 155. Kyoto Biken Animal Biological Vaccine Product Portfolios and Specifications
Table 156. Kyoto Biken Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Kyoto Biken Main Business
Table 158. Kyoto Biken Latest Developments
Table 159. FATRO Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 160. FATRO Animal Biological Vaccine Product Portfolios and Specifications
Table 161. FATRO Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. FATRO Main Business
Table 163. FATRO Latest Developments
Table 164. Vaksindo Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 165. Vaksindo Animal Biological Vaccine Product Portfolios and Specifications
Table 166. Vaksindo Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Vaksindo Main Business
Table 168. Vaksindo Latest Developments
Table 169. Bio-Labs Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 170. Bio-Labs Animal Biological Vaccine Product Portfolios and Specifications
Table 171. Bio-Labs Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Bio-Labs Main Business
Table 173. Bio-Labs Latest Developments
Table 174. Avimex Animal Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 175. Avimex Animal Animal Biological Vaccine Product Portfolios and Specifications
Table 176. Avimex Animal Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Avimex Animal Main Business
Table 178. Avimex Animal Latest Developments
Table 1. Animal Biological Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Animal Biological Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Subcutaneous
Table 5. Major Players of Intramuscular
Table 6. Major Players of Others
Table 7. Global Animal Biological Vaccine Sales by Type (2020-2025) & (K Units)
Table 8. Global Animal Biological Vaccine Sales Market Share by Type (2020-2025)
Table 9. Global Animal Biological Vaccine Revenue by Type (2020-2025) & ($ million)
Table 10. Global Animal Biological Vaccine Revenue Market Share by Type (2020-2025)
Table 11. Global Animal Biological Vaccine Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Animal Biological Vaccine Sale by Application (2020-2025) & (K Units)
Table 13. Global Animal Biological Vaccine Sale Market Share by Application (2020-2025)
Table 14. Global Animal Biological Vaccine Revenue by Application (2020-2025) & ($ million)
Table 15. Global Animal Biological Vaccine Revenue Market Share by Application (2020-2025)
Table 16. Global Animal Biological Vaccine Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Animal Biological Vaccine Sales by Company (2020-2025) & (K Units)
Table 18. Global Animal Biological Vaccine Sales Market Share by Company (2020-2025)
Table 19. Global Animal Biological Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Animal Biological Vaccine Revenue Market Share by Company (2020-2025)
Table 21. Global Animal Biological Vaccine Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Animal Biological Vaccine Producing Area Distribution and Sales Area
Table 23. Players Animal Biological Vaccine Products Offered
Table 24. Animal Biological Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Animal Biological Vaccine Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Animal Biological Vaccine Sales Market Share Geographic Region (2020-2025)
Table 29. Global Animal Biological Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Animal Biological Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Animal Biological Vaccine Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Animal Biological Vaccine Sales Market Share by Country/Region (2020-2025)
Table 33. Global Animal Biological Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Animal Biological Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Animal Biological Vaccine Sales by Country (2020-2025) & (K Units)
Table 36. Americas Animal Biological Vaccine Sales Market Share by Country (2020-2025)
Table 37. Americas Animal Biological Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Animal Biological Vaccine Sales by Type (2020-2025) & (K Units)
Table 39. Americas Animal Biological Vaccine Sales by Application (2020-2025) & (K Units)
Table 40. APAC Animal Biological Vaccine Sales by Region (2020-2025) & (K Units)
Table 41. APAC Animal Biological Vaccine Sales Market Share by Region (2020-2025)
Table 42. APAC Animal Biological Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Animal Biological Vaccine Sales by Type (2020-2025) & (K Units)
Table 44. APAC Animal Biological Vaccine Sales by Application (2020-2025) & (K Units)
Table 45. Europe Animal Biological Vaccine Sales by Country (2020-2025) & (K Units)
Table 46. Europe Animal Biological Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Animal Biological Vaccine Sales by Type (2020-2025) & (K Units)
Table 48. Europe Animal Biological Vaccine Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Animal Biological Vaccine Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Animal Biological Vaccine Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Animal Biological Vaccine Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Animal Biological Vaccine Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Animal Biological Vaccine
Table 54. Key Market Challenges & Risks of Animal Biological Vaccine
Table 55. Key Industry Trends of Animal Biological Vaccine
Table 56. Animal Biological Vaccine Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Animal Biological Vaccine Distributors List
Table 59. Animal Biological Vaccine Customer List
Table 60. Global Animal Biological Vaccine Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Animal Biological Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Animal Biological Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Animal Biological Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Animal Biological Vaccine Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Animal Biological Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Animal Biological Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Animal Biological Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Animal Biological Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Animal Biological Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Animal Biological Vaccine Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Animal Biological Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Animal Biological Vaccine Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Animal Biological Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Merck Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 75. Merck Animal Biological Vaccine Product Portfolios and Specifications
Table 76. Merck Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Merck Main Business
Table 78. Merck Latest Developments
Table 79. Zoetis Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Zoetis Animal Biological Vaccine Product Portfolios and Specifications
Table 81. Zoetis Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Zoetis Main Business
Table 83. Zoetis Latest Developments
Table 84. Merial/Sanofi Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Merial/Sanofi Animal Biological Vaccine Product Portfolios and Specifications
Table 86. Merial/Sanofi Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Merial/Sanofi Main Business
Table 88. Merial/Sanofi Latest Developments
Table 89. Boehringer Ingelheim Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Boehringer Ingelheim Animal Biological Vaccine Product Portfolios and Specifications
Table 91. Boehringer Ingelheim Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Boehringer Ingelheim Main Business
Table 93. Boehringer Ingelheim Latest Developments
Table 94. Ceva Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Ceva Animal Biological Vaccine Product Portfolios and Specifications
Table 96. Ceva Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Ceva Main Business
Table 98. Ceva Latest Developments
Table 99. CAHIC Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CAHIC Animal Biological Vaccine Product Portfolios and Specifications
Table 101. CAHIC Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. CAHIC Main Business
Table 103. CAHIC Latest Developments
Table 104. HVRI Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. HVRI Animal Biological Vaccine Product Portfolios and Specifications
Table 106. HVRI Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. HVRI Main Business
Table 108. HVRI Latest Developments
Table 109. Ringpu Biology Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Ringpu Biology Animal Biological Vaccine Product Portfolios and Specifications
Table 111. Ringpu Biology Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Ringpu Biology Main Business
Table 113. Ringpu Biology Latest Developments
Table 114. Yebio Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Yebio Animal Biological Vaccine Product Portfolios and Specifications
Table 116. Yebio Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Yebio Main Business
Table 118. Yebio Latest Developments
Table 119. DHN Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. DHN Animal Biological Vaccine Product Portfolios and Specifications
Table 121. DHN Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. DHN Main Business
Table 123. DHN Latest Developments
Table 124. WINSUN Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. WINSUN Animal Biological Vaccine Product Portfolios and Specifications
Table 126. WINSUN Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. WINSUN Main Business
Table 128. WINSUN Latest Developments
Table 129. Elanco/Eli Lilly Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Elanco/Eli Lilly Animal Biological Vaccine Product Portfolios and Specifications
Table 131. Elanco/Eli Lilly Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Elanco/Eli Lilly Main Business
Table 133. Elanco/Eli Lilly Latest Developments
Table 134. Virbac Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Virbac Animal Biological Vaccine Product Portfolios and Specifications
Table 136. Virbac Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Virbac Main Business
Table 138. Virbac Latest Developments
Table 139. Jinyu Bio-Technology Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Jinyu Bio-Technology Animal Biological Vaccine Product Portfolios and Specifications
Table 141. Jinyu Bio-Technology Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Jinyu Bio-Technology Main Business
Table 143. Jinyu Bio-Technology Latest Developments
Table 144. ChengDu Tecbond Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 145. ChengDu Tecbond Animal Biological Vaccine Product Portfolios and Specifications
Table 146. ChengDu Tecbond Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. ChengDu Tecbond Main Business
Table 148. ChengDu Tecbond Latest Developments
Table 149. CAVAC Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 150. CAVAC Animal Biological Vaccine Product Portfolios and Specifications
Table 151. CAVAC Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. CAVAC Main Business
Table 153. CAVAC Latest Developments
Table 154. Kyoto Biken Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 155. Kyoto Biken Animal Biological Vaccine Product Portfolios and Specifications
Table 156. Kyoto Biken Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Kyoto Biken Main Business
Table 158. Kyoto Biken Latest Developments
Table 159. FATRO Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 160. FATRO Animal Biological Vaccine Product Portfolios and Specifications
Table 161. FATRO Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. FATRO Main Business
Table 163. FATRO Latest Developments
Table 164. Vaksindo Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 165. Vaksindo Animal Biological Vaccine Product Portfolios and Specifications
Table 166. Vaksindo Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Vaksindo Main Business
Table 168. Vaksindo Latest Developments
Table 169. Bio-Labs Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 170. Bio-Labs Animal Biological Vaccine Product Portfolios and Specifications
Table 171. Bio-Labs Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Bio-Labs Main Business
Table 173. Bio-Labs Latest Developments
Table 174. Avimex Animal Basic Information, Animal Biological Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 175. Avimex Animal Animal Biological Vaccine Product Portfolios and Specifications
Table 176. Avimex Animal Animal Biological Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Avimex Animal Main Business
Table 178. Avimex Animal Latest Developments
LIST OF FIGURES
Figure 1. Picture of Animal Biological Vaccine
Figure 2. Animal Biological Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Animal Biological Vaccine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Animal Biological Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Animal Biological Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Animal Biological Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Animal Biological Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Subcutaneous
Figure 13. Product Picture of Intramuscular
Figure 14. Product Picture of Others
Figure 15. Global Animal Biological Vaccine Sales Market Share by Type in 2025
Figure 16. Global Animal Biological Vaccine Revenue Market Share by Type (2020-2025)
Figure 17. Animal Biological Vaccine Consumed in Porcine
Figure 18. Global Animal Biological Vaccine Market: Porcine (2020-2025) & (K Units)
Figure 19. Animal Biological Vaccine Consumed in Poultry
Figure 20. Global Animal Biological Vaccine Market: Poultry (2020-2025) & (K Units)
Figure 21. Animal Biological Vaccine Consumed in Livestock
Figure 22. Global Animal Biological Vaccine Market: Livestock (2020-2025) & (K Units)
Figure 23. Animal Biological Vaccine Consumed in Companion Animals
Figure 24. Global Animal Biological Vaccine Market: Companion Animals (2020-2025) & (K Units)
Figure 25. Animal Biological Vaccine Consumed in Aquaculture
Figure 26. Global Animal Biological Vaccine Market: Aquaculture (2020-2025) & (K Units)
Figure 27. Global Animal Biological Vaccine Sale Market Share by Application (2024)
Figure 28. Global Animal Biological Vaccine Revenue Market Share by Application in 2025
Figure 29. Animal Biological Vaccine Sales by Company in 2025 (K Units)
Figure 30. Global Animal Biological Vaccine Sales Market Share by Company in 2025
Figure 31. Animal Biological Vaccine Revenue by Company in 2025 ($ millions)
Figure 32. Global Animal Biological Vaccine Revenue Market Share by Company in 2025
Figure 33. Global Animal Biological Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Animal Biological Vaccine Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Animal Biological Vaccine Sales 2020-2025 (K Units)
Figure 36. Americas Animal Biological Vaccine Revenue 2020-2025 ($ millions)
Figure 37. APAC Animal Biological Vaccine Sales 2020-2025 (K Units)
Figure 38. APAC Animal Biological Vaccine Revenue 2020-2025 ($ millions)
Figure 39. Europe Animal Biological Vaccine Sales 2020-2025 (K Units)
Figure 40. Europe Animal Biological Vaccine Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Animal Biological Vaccine Sales 2020-2025 (K Units)
Figure 42. Middle East & Africa Animal Biological Vaccine Revenue 2020-2025 ($ millions)
Figure 43. Americas Animal Biological Vaccine Sales Market Share by Country in 2025
Figure 44. Americas Animal Biological Vaccine Revenue Market Share by Country (2020-2025)
Figure 45. Americas Animal Biological Vaccine Sales Market Share by Type (2020-2025)
Figure 46. Americas Animal Biological Vaccine Sales Market Share by Application (2020-2025)
Figure 47. United States Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Animal Biological Vaccine Sales Market Share by Region in 2025
Figure 52. APAC Animal Biological Vaccine Revenue Market Share by Region (2020-2025)
Figure 53. APAC Animal Biological Vaccine Sales Market Share by Type (2020-2025)
Figure 54. APAC Animal Biological Vaccine Sales Market Share by Application (2020-2025)
Figure 55. China Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. India Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Animal Biological Vaccine Sales Market Share by Country in 2025
Figure 63. Europe Animal Biological Vaccine Revenue Market Share by Country (2020-2025)
Figure 64. Europe Animal Biological Vaccine Sales Market Share by Type (2020-2025)
Figure 65. Europe Animal Biological Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Germany Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. France Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Animal Biological Vaccine Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Animal Biological Vaccine Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Animal Biological Vaccine Sales Market Share by Application (2020-2025)
Figure 74. Egypt Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Animal Biological Vaccine in 2025
Figure 80. Manufacturing Process Analysis of Animal Biological Vaccine
Figure 81. Industry Chain Structure of Animal Biological Vaccine
Figure 82. Channels of Distribution
Figure 83. Global Animal Biological Vaccine Sales Market Forecast by Region (2026-2031)
Figure 84. Global Animal Biological Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Animal Biological Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Animal Biological Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Animal Biological Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Animal Biological Vaccine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Animal Biological Vaccine
Figure 2. Animal Biological Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Animal Biological Vaccine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Animal Biological Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Animal Biological Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Animal Biological Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Animal Biological Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Subcutaneous
Figure 13. Product Picture of Intramuscular
Figure 14. Product Picture of Others
Figure 15. Global Animal Biological Vaccine Sales Market Share by Type in 2025
Figure 16. Global Animal Biological Vaccine Revenue Market Share by Type (2020-2025)
Figure 17. Animal Biological Vaccine Consumed in Porcine
Figure 18. Global Animal Biological Vaccine Market: Porcine (2020-2025) & (K Units)
Figure 19. Animal Biological Vaccine Consumed in Poultry
Figure 20. Global Animal Biological Vaccine Market: Poultry (2020-2025) & (K Units)
Figure 21. Animal Biological Vaccine Consumed in Livestock
Figure 22. Global Animal Biological Vaccine Market: Livestock (2020-2025) & (K Units)
Figure 23. Animal Biological Vaccine Consumed in Companion Animals
Figure 24. Global Animal Biological Vaccine Market: Companion Animals (2020-2025) & (K Units)
Figure 25. Animal Biological Vaccine Consumed in Aquaculture
Figure 26. Global Animal Biological Vaccine Market: Aquaculture (2020-2025) & (K Units)
Figure 27. Global Animal Biological Vaccine Sale Market Share by Application (2024)
Figure 28. Global Animal Biological Vaccine Revenue Market Share by Application in 2025
Figure 29. Animal Biological Vaccine Sales by Company in 2025 (K Units)
Figure 30. Global Animal Biological Vaccine Sales Market Share by Company in 2025
Figure 31. Animal Biological Vaccine Revenue by Company in 2025 ($ millions)
Figure 32. Global Animal Biological Vaccine Revenue Market Share by Company in 2025
Figure 33. Global Animal Biological Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Animal Biological Vaccine Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Animal Biological Vaccine Sales 2020-2025 (K Units)
Figure 36. Americas Animal Biological Vaccine Revenue 2020-2025 ($ millions)
Figure 37. APAC Animal Biological Vaccine Sales 2020-2025 (K Units)
Figure 38. APAC Animal Biological Vaccine Revenue 2020-2025 ($ millions)
Figure 39. Europe Animal Biological Vaccine Sales 2020-2025 (K Units)
Figure 40. Europe Animal Biological Vaccine Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Animal Biological Vaccine Sales 2020-2025 (K Units)
Figure 42. Middle East & Africa Animal Biological Vaccine Revenue 2020-2025 ($ millions)
Figure 43. Americas Animal Biological Vaccine Sales Market Share by Country in 2025
Figure 44. Americas Animal Biological Vaccine Revenue Market Share by Country (2020-2025)
Figure 45. Americas Animal Biological Vaccine Sales Market Share by Type (2020-2025)
Figure 46. Americas Animal Biological Vaccine Sales Market Share by Application (2020-2025)
Figure 47. United States Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Animal Biological Vaccine Sales Market Share by Region in 2025
Figure 52. APAC Animal Biological Vaccine Revenue Market Share by Region (2020-2025)
Figure 53. APAC Animal Biological Vaccine Sales Market Share by Type (2020-2025)
Figure 54. APAC Animal Biological Vaccine Sales Market Share by Application (2020-2025)
Figure 55. China Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. India Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Animal Biological Vaccine Sales Market Share by Country in 2025
Figure 63. Europe Animal Biological Vaccine Revenue Market Share by Country (2020-2025)
Figure 64. Europe Animal Biological Vaccine Sales Market Share by Type (2020-2025)
Figure 65. Europe Animal Biological Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Germany Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. France Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Animal Biological Vaccine Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Animal Biological Vaccine Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Animal Biological Vaccine Sales Market Share by Application (2020-2025)
Figure 74. Egypt Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Animal Biological Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Animal Biological Vaccine in 2025
Figure 80. Manufacturing Process Analysis of Animal Biological Vaccine
Figure 81. Industry Chain Structure of Animal Biological Vaccine
Figure 82. Channels of Distribution
Figure 83. Global Animal Biological Vaccine Sales Market Forecast by Region (2026-2031)
Figure 84. Global Animal Biological Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Animal Biological Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Animal Biological Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Animal Biological Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Animal Biological Vaccine Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Single-Use Technologies for the Biologic Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
109 pages
Global Retinal Drugs and Biologics Market Growth 2025-2031
US$ 3,660.00
October 2025
107 pages
Global Non-animal Capsule Market Growth 2025-2031
US$ 3,660.00
October 2025
141 pages
